M. Law
Surgery · British medical journal · 2000–2016
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 18 researchers here, as inferred from the citation graph.
Subfields
- Surgery — 51 citations into it; #63 of 1,106 by trust here, #162 by citations
- Cancer Research — 13 citations into it; #1,399 of 1,780 by trust here, #938 by citations
Whom M. Law trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Law overall
- I. Graham
- H. Khurana
- S. Kanawjia
- Deborah Lawlor
- G. Danaei
- John P. A. Ioannidis
- T. Ivanova
- A. Marangoni
- George Davey Smith
- Nirmala Chongtham
Papers from M. Law's perspective
Ordered by how strongly the researchers M. Law trusts endorse each paper. Same corpus, a different order for every researcher.
- Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (The Lancet)
- Bias and causal associations in observational research.
- Use of statins and the risk of death in patients with prostate cancer. (Journal of Clinical Oncology)
- Evaluating non-randomised intervention studies. (Health Technology Assessment)
- Statins and the risk of colorectal cancer. (New England Journal of Medicine)
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial… (European Heart Journal)
- Nonspecific medication side effects and the nocebo phenomenon. (Journal of the American Medical Association (JAMA))
- When are randomised trials unnecessary? Picking signal from noise (British medical journal)
- Statin safety: a systematic review. (American Journal of Cardiology)
Their papers
- Statin safety: a systematic review. (2006) — 805 citations
- Interpretation of the evidence for the efficacy and safety of statin therapy. (2016) — 1,672 citations
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies (2009) — 2,754 citations
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis (2003) — 1,858 citations
- Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. (2003) — 1,019 citations
- A strategy to reduce cardiovascular disease by more than 80% (2003) — 1,665 citations
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis (2002) — 2,104 citations
- Plant sterol and stanol margarines and health (2000) — 791 citations